All News

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Negotiations on a new coronavirus disease 2019 (COVID-19) relief package are reportedly on the brink of failure; as more than 100 COVID-19 vaccine candidates continue to be examined in clinical trials, some hints on pricing have emerged; the Trump administration removed its warnings on all international travel to Americans amid COVID-19.

In the primary analysis of a phase 3 study, ruxolitinib reduced spleen length and symptoms in patients with myelofibrosis, according to results published in British Journal of Haemotology.

This week, the top managed care news included CMS updates on telehealth and more; COVID-19 vaccine developments and remaining challenges; a study examines the impact of state policies on life expectancy.

Researchers found that patients with idiopathic pulmonary fibrosis (IPF) are at increased risk of developing several forms of cancer compared with the general population.

clonoSEQ, from Adaptive Biotechnologies, can detect 1 cancer cell among a million healthy cells.

A new analysis offers insights into how ozanimod works in patients with relapsing multiple sclerosis, as well as the impact of higher dosage.

Just like in clinical trials, a real-world analysis of patients with psoriatic arthritis who were treated with secukinumab achieved minimal disease activity, as well as other improvements.

Improving on the ability to confirm diagnosis of Parkinson disease (PD) earlier and determining who is at risk for PD were referenced as key factors in further slowing progression of the disease, according to review findings.

Results from a phase 2 trial of pembrolizumab as immune checkpoint inhibition against 5 types of solid tumors show that circulating tumor DNA (ctDNA) may be used to accurately predict response to treatment.

Health care workers of color are nearly 2 times more likely than their white colleagues to test positive for coronavirus disease 2019; Teladoc Health announced an agreement to acquire Livongo, a diabetes coaching company, for $18.5 billion; the CDC has issued a warning against ingesting alcohol-based hand sanitizer in response to reports of poisonings in the United States.

Robin Gelburd, JD, president of FAIR Health, discusses telehealth growth in May medical claims.

Bacterial changes in the oral cavity from immunosuppression, not HIV itself, are more likely to blame for the greater incidence of oral caries in children 6 months to 6 years, reports a study from the Department of Oral Biology at the Rutgers University School of Dental Medicine.

Researchers found that cough reflex sensitivity is amplified during chronic obstructive pulmonary disease (COPD) exacerbation and reduces after recovery, while its persistence can help serve as a predictor for future exacerbations.

The American College of Cardiology updates guidance on prescribing SGLT2 inhibitors and GLP-1 receptor agonists to patients with type 2 diabetes and cardiovascular disease or CV risk.

Hinge Health announced the expansion of its clinical and technical musculoskeletal (MSK) capabilities to cover the full continuum of MSK care. The move will provide the most complete back and joint health solution to employers and health plans.

A study based on real-world data collected from the West German Headache Center at the University Hospital Essen, Germany, concluded erenumab appears to be a promising treatment option for patients with highly therapy-refractory migraine.

Results from a large population-based cohort study, published in Arthritis Care & Research, found individuals with rheumatoid arthritis (RA) had a lower rate of incident type 2 diabetes (T2D) compared with the general non-RA population and cohorts with with hypertension, osteoarthritis (OA), and psoriatic arthritis (PsA).

Several issues are affecting the uptake of telehealth services among older adults; phase 1 trials results from Australia demonstrate immune responses from a coronavirus disease 2019 (COVID-19) vaccine candidate; Purdue Pharma could be on the hook for an $18.1-billion fine from the Justice Department.

Among the changes announced this week include the expanded use of telehealth in Medicare, giving payment parity to hospital outpatient surgery centers, simplifying evaluation and management codes, and changing performance measures for accountable care organizations (ACOs).

The coronavirus disease 2019 (COVID-19) vaccines that are leading the pack are utilizing a new vaccine technology that has never been approved for human use by the FDA. As a result, there are a lot of unknowns.

New study results published in JAMA Ophthalmology suggest researchers can leverage big data to triage ophthalmic clinic appointments, balancing the glaucoma progression risk against the morbidity risk from coronavirus disease 2019 (COVID-19) exposure during ophthalmic care.

Evidence may support a greater comorbidity burden among patients with heart failure with preserved ejection fraction (HFpEF) or reduced ejection fraction (HFrEF), although this finding was shown to be worse among women with HFpEF.

Life expectancy trends in the United States "paint a troubling portrait of life and death," according to a new study published in The Milibank Quarterly. State policies have played an important role in the stagnation and recent decline in life expectancy.

Cognitive behavioral therapy for insomnia delivered via telemedicine was found to be noninferior to in-person delivery in managing severity, with similar improvements in daytime functioning exhibited between the 2 methods, according to study findings.

A Health Affairs study found 49% of all rural low-income communities have no intensive care unit beds; New York loosened its restrictions granting hospitals and care facilities some legal immunity during the coronavirus disease 2019 (COVID-19) pandemic; all students in New Jersey will be required to wear masks in school.

Higher-income countries are seeing their rates of premenopausal breast cancer increase faster, whereas cases of postmenopausal breast cancer are increasing in number faster in lower-income studies.

The ruling reversed a lower court ruling regarding the drug discount program for hospitals that serve patients covered by Medicaid.